Pathfinder is an independent boutique fund manager based in Auckland. We value transparency, social responsibility and aligning interests with our investors. We are also advocates of reducing the complexity of investment products for NZ investors.
Renewables power to new highs
The trend towards renewables with a greater focus on ESG and the carbon footprint of stocks has only just begun
MORE»What does the future hold for oil?
Hamesh Sharma of Pathfinder with an overview of the implications for energy stocks and airlines such as Air New Zealand. What does the future hold for oil?
MORE»Recovery from coronavirus – a buying opportunity?
Hamesh Sharma takes a look at historic market-impacting world events; how they played out and markets recovered; and what this could mean for a recovery from Covid-19's present market grip.
MORE»No room for complacency in 2020
Markets ended 2019 in a festive mood, and the positive trend has continued in 2020 with equity markets powering to fresh all-time highs.
MORE»Should Meridian call Rio’s bluff?
Rio Tinto has a caused a stir among electricity gentailers this week. What it might mean for Meridian going forward.
MORE»Not all high yielding stocks are equal. Here's three that deserve second-thoughts
It's easy for investors to be allured by high-dividend yields, particularly in the current low interest rate environment; but it pays to be wary.
MORE»Taking the carbon out of KiwiSaver
Pathfinder's new CareSaver KiwiSaver Scheme is the first actively managed KiwiSaver fund to assess and report the carbon intensity of its portfolio; Here's how it's going.
MORE»Why are Australian banks investing in nuclear weapons companies?
New Zealanders have strong and clear opinions about where our money is invested, and not supporting the manufacture of nuclear weapons is right at the top of the list. Our country has a long and proud anti-nuclear weapon history.
MORE»Cannasouth breaks listing drought
The IPO of medicinal cannabis company Cannasouth has broken a 2-year listing drought for the NZX. Unfortunately, for NZX investors we are not impressed by the latest listing on the market, which we see as a speculative pre-revenue business that was highly priced.
MORE»Asset allocation: Modern Portfolio Theory v Behavioural Finance
In the financial world, a great many asset allocation decisions are made using the Modern Portfolio Theory (MPT), but what about Behavioural Finance? Karl Geal-Otter investigates.
MORE»Finding the Next Xero
When Xero delisted from the NZX, it was truly a sad day for the NZ market. While we have other great success stories such as Ryman Healthcare, and more recently A2 Milk, Xero was a great example of a Kiwi company competing in the technology space and experiencing success on the global stage.
MORE»Investing: Don’t forget about the cycle
Another fast start to the year in financial markets. Following a disappointing end to 2018, equity markets rallied during January, with the MSCI World finishing the month up 7.7% (in USD terms).
MORE»